# A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

> **NCT07239973** · PHASE1 · RECRUITING · sponsor: **BrightGene Bio-Medical Technology Co., Ltd.** · enrollment: 75 (estimated)

## Conditions studied

- Healthy
- Non-diabetic Overweight or Obese

## Interventions

- **DRUG:** BGM0504 tablets
- **DRUG:** Placebo tablets

## Key facts

- **NCT ID:** NCT07239973
- **Lead sponsor:** BrightGene Bio-Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239973, "A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT07239973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*